News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Aleta Biotherapeutics Receives Innovation Passport Designation for Biologic CAR T-Cell Therapy Engager ALETA-001
Tuesday, November 08, 2022Aleta Biotherapeutics Aleta a privately held immunooncology company with novel biologic CAR T engagers that work in synergy with cell therapies to improve outcomes for patients
Nucleai Launches New Multiplex Imaging Spatial Analysis Solution to Increase Reliability and Speed of Immunofluorescence Analysis for Drug Discovery and Development
Tuesday, November 08, 2022Nucleai a leader in AIpowered spatial biology today announced the expansion of its spatial biology platform to include a new generation of multiplex immunofluorescence mIF analysis that uses deep learning to establish new levels of accuracy speed and...
Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study
Friday, November 04, 2022Shuttle Pharmaceuticals Holdings Inc a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy RT while reducing its side effects today announced it has enga...
Yuyu Pharma attendance at European Pharmaceutical Conference
Friday, November 04, 2022Yuyu Pharmas CEO Robert Yu has been actively participating in biopharmaceutical conferences specifically BIOEurope in Leipzig and CPHI in Frankfurt held in Germany
QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform
Thursday, November 03, 2022QuantuMDx Group Limited a UKbased developer of transformational PointofNeed molecular diagnostics and AMenarini Diagnostics SrI Menarini are pleased to announce an exclusive distribution agreement for QuantuMDxs QPOC platform in the UK and France
OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals
Thursday, November 03, 2022OrsoBio Inc a clinicalstage biopharmaceutical company developing treatments for severe metabolic disorders today announced its acquisition of assets relating to the Liver X Receptor LXR inverse agonist program from Phenex Pharmaceuticals including le...
Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine
Wednesday, November 02, 2022Lonza a preferred partner to the pharmaceutical biotech and nutraceutical markets has launched an innovative new capsule solution for intestinal enteric drug delivery The Capsugel Enprotect capsule does not disintegrate during stomach transit and onl...
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™, a New and Innovative Ready-To-Use Vial Platform
Wednesday, November 02, 2022Stevanato Group SpA a global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries and Gerresheimer AG a leading global provider of healthcare beauty and drug delivery sy...
Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028
Tuesday, November 01, 2022Small Pharma Inc a biotechnology company focused on shortacting psychedelicassisted therapies for mental health conditions today announces that it has received approval from the UK Medicines and Healthcare products Regulatory Authority the MHRA and t...
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis
Tuesday, November 01, 2022Karyopharm Therapeutics Inc a pharmaceutical company specializing in innovative cancer therapies and the Menarini Group a leading international pharmaceutical company announced today that the European
